Skip to main content

Table 1 Definition of biomarkers and subtypes according to the national institute of health[1]

From: Role of biomarkers in the management of antibiotic therapy: an expert panel review: I – currently available biomarkers for clinical use in acute infections

Denomination

Definition

Biomarker

Biological characteristics objectively measured, and used as a marker either of a normal or pathological biological pathway, or of a pharmacological response to a specific intervention

Biomarker type 0

Biological maker of the disease course, linked to a recognised clinical variable

Biomarker type I

Biological marker reflecting the effects of a therapy, and linked to its mechanism of action

Biomarker type II

Biological marker used as a surrogate endpoint, where changes in the biomarker levels are associated to a clinical benefit or to an increased risk.